Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients-Reference-Cited by-同舟云学术

Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients

Published:2019-06-04 Issue:21 Volume:321 Page:2082
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Matta Murali K.¹,Zusterzeel Robbert¹,Pilli Nageswara R.¹,Patel Vikram¹,Volpe Donna A.¹,Florian Jeffry¹,Oh Luke²,Bashaw Edward²,Zineh Issam²,Sanabria Carlos³,Kemp Sarah³,Godfrey Anthony³,Adah Steven⁴,Coelho Sergio⁴,Wang Jian⁵,Furlong Lesley-Anne⁵,Ganley Charles⁵,Michele Theresa⁴,Strauss David G.¹

Affiliation:

1. Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland

2. Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland

3. Spaulding Clinical Research, West Bend, Wisconsin

4. Division of Nonprescription Drug Products, Office of Drug Evaluation IV, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland

5. Office of Drug Evaluation IV, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jama/article-pdf/321/21/2082/17623676/jama_matta_2019_pc_190002.pdf

Reference21 articles.

1. Labeling and effectiveness testing: sunscreen drug products for over-the-counter human use: final rule.;US Food and Drug Administration, HHS;Fed Regist,2011

2. Human safety and efficacy of ultraviolet filters and sunscreen products.;Nash;Dermatol Clin,2006

3. Safety threshold considerations for sunscreen systemic exposure: a simulation study.;Wang;Clin Pharmacol Ther,2019

4. Sunscreen drug products for over-the-counter human use: proposed rule.;US Food and Drug Administration (FDA);Fed Regist,2019

5. Maximal usage trial: an overview of the design of systemic bioavailability trial for topical dermatological products.;Bashaw;Ther Innov Regul Sci,2015

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increasing exposure to the UV filters octocrylene and 2-ethylhexyl salicylate in Germany from 1996 to 2020: Human biomonitoring in 24-h urine samples of the German Environmental Specimen Bank (ESB);Environment International;2023-12

2. Enhancement of Skin Permeability Prediction through PBPK Modeling, Bayesian Inference, and Experiment Design;Pharmaceutics;2023-11-24

3. Research on Permeation Influencing Factors of Cosmetics UV Filters and Improve In Vitro Permeation Tests (IVPTs);Processes;2023-11-02

4. Stoffmonographie für Octocrylen – HBM-Werte für die Metaboliten 2-Cyano-3,3-diphenylacrylsäure (CPAA) und 2-(Carboxymethyl)butyl 2-cyano-3,3-diphenylacrylat (Dinor-OC-Carbonsäure, DOCCA) im Urin der Allgemeinbevölkerung;Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz;2023-11

5. A novel online survey approach designed to measure consumer sunscreen application thickness—implications for estimating environmental emissions;Journal of Exposure Science & Environmental Epidemiology;2023-10-28